IMP4297

IMP4297 · Impact Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for IMP4297, covering 2024-09-19 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer [Phase 2]